Octave Specialty Group earnings release, May 6, 2026

Octave Specialty Group Inc (OSG) · Form 8-K, Item 2.02 · Filed · SEC filing

Octave Specialty Group Reports First Quarter 2026 Results

• Total P&C premium production increased

66% for the quarter to $531 million

• Insurance Distribution Segment

◦ Total revenue grew

92% to

$79 million, including the impact of the October 2025 acquisition of ArmadaCare

◦ Organic revenue growth equaled 42%

◦ Ne t income to Shareholders of $13 million, compared to net loss of

$(3) million in 1Q25

◦ Adjusted EBITDA to Shareholders of $25 million, compared to

$7 million in 1Q25

◦ Pre-tax income and Adjusted EBITDA margin to shareholders reached 16% and 32%, respectively

• Specialty P&C Insurance Segment ("Everspan")

◦ Gross and net premiums written of $104 million and $32 million were up 19% and 80%, respectively

◦ Net loss was $(8) million, compared to net income of $1 million in 1Q25

▪ The first quarter 2026 net loss was driven primarily by losses and LAE from the settlement of a potential litigation matter related to an insurance claim

◦ Adjusted net income was $1.2 million, compared to Adjusted net income of $1.5 million a year ago

◦ Adjusted EBITDA to Shareholders of $1.6 million, up 2% compared to 1Q25

NEW YORK, NY, May 6, 2026 (BUSINESS WIRE) — Octave Specialty Group, Inc. (NYSE: OSG) ("Octave" or "OSG"), a global specialty insurance firm, today reported its results for the First Quarter 2026.

"I am very pleased with our first quarter results," said Claude LeBlanc, President and Chief Executive Officer of Octave. "Our core Insurance Distribution business delivered 92% revenue growth, 42% organic growth, the rest from our recent ArmadaCare acquisition. Insurance Distribution Adjusted EBITDA increased to $25 million, nearly four times the same period last year. The diversification of our distribution platform demonstrated the resilience and value of the Octave platform as we delivered our strongest quarter yet, even as we witnessed some headwinds in certain segments of the market."

LeBlanc continued, “Everspan's turnaround is also gaining momentum. Gross premiums written topped $100 million, up 19%, while net premiums written grew 80%. Regrettably, we experienced some adverse development this quarter from the settlement of a potential litigation matter related to an insurance claim from a program in run-off. This loss was primarily attributable to legal expenses incurred in connection with the settlement which had an adverse impact on our reported quarterly underwriting results. Importantly however, our active programs were running at a loss ratio of 57% in the first quarter, right in line with the current accident year performance." LeBlanc concluded, "Overall, this quarter's results reflect solid execution and reinforces our confidence in the strength of our business"¹

(1)

Some financial data in this press release may not add up due to rounding

(2)

See Non-GAAP Financial Data section of this press release for further information

(3)

Per diluted share includes the impact of adjusting redeemable noncontrolling interests to current redemption value

First Quarter 2026 Summary

(4)

Total revenue from continuing operations for the first quarter of 2026 was $104 million, an increase of 66% compared to the $63 million in the same prior-year period. The growth in total revenue was driven by the Insurance Distribution segment, which included the acquisition of ArmadaCare and organic revenue growth of 42%.

Net (loss) from continuing operations to shareholders for the first quarter of 2026 was $(7) million compared to $(16) million in the same prior-year period. The improvement was attributable to our Insurance Distribution segment, which reported net income of $13 million compared to a net loss of $(3) million in the prior year quarter. The strong results in the Insurance Distribution business were partially offset by a net loss of $(8) million in our Specialty Property & Casualty segment, which included $2.1 million of losses and $5.8 million of LAE (legal expenses) to settle a potential litigation matter related to an insurance claim. Adjusted net income to shareholders, which excludes non-recurring expenses along with other items, was $17 million compared to a net loss of $(6) million in the same prior-year period.

Adjusted EBITDA from continuing operations to shareholders for the first quarter of 2026 was $20.1 million compared to $(1.3) million in the same prior-year period. The improvement was driven by an $18.2 million increase in Insurance Distribution Adjusted EBITDA. Our Insurance Distribution results reflected the first full quarter of ArmadaCare and the seasonal impact of our A&H business, in addition to growth across our core MGA platform. Everspan reported an Adjusted EBITDA of $1.6 million, up 2% from the prior-year period.

Included within first quarter 2026 results was a Corporate net (loss) of $(12) million compared to a net (loss) of $(14) million in the first quarter of 2025. Corporate Adjusted EBITDA was a (loss) of $(7) million compared to a loss of $(10) million in the first quarter of 2025.

(4)

For definitions of each non-GAAP measure referred to above, as well as reconciliation of such non-GAAP measures to their most directly comparable GAAP measures, see "Non-GAAP Financial Measures" below.²

Earnings Call and Webcast

On May 7, 2026, at 8:30am ET, Claude LeBlanc, President and Chief Executive Officer, and David Trick, Executive Vice President and Chief Financial Officer, will discuss Octave's first quarter 2026 results during a conference call. A live audio webcast of the call will be available through the Investor Relations section of Octave’s website, https://octavegroup.com/investor-relations/events-and-presentations/. Participants may also listen via telephone by dialing (877) 407-9716 or (201) 493-6779.... (truncated)13759400.

Additional information is included in an operating supplement and presentations on Octave's website, www.octavegroup.com.

Results of Operations by Segment

Insurance Distribution Segment

(1)

After the impact of noncontrolling interests

(2)

Represents Pretax income (loss) to shareholders divided by total revenues

(3)

See Non-GAAP Financial Data section of this press release for further information

(4)

Represents Adjusted EBITDA to shareholders divided by total revenues

Specialty Property & Casualty Insurance Segment

(1)

See Non-GAAP Financial Data section of this press release for further information³

OSG Corporate (holding company only)

OSG on a standalone basis, excluding its ownership interests in its Specialty P&C Insurance and Insurance Distribution subsidiaries, had net assets of $61 million as of March 31, 2026. Assets included cash and liquid securities of $39 million and other investments of $22 million.

Consolidated Octave Specialty Group, Inc. Stockholders' Equity and NCI Impact to EPS

Stockholders’ equity attributable to common shareholders at March 31, 2026, was $713 million, or $15.83 per share compar ed to $716 million or $15.90 p er share as of December 31, 2025. The decline was primarily a result of the total comprehensive loss attributable to common shareholders of $(14) million, partially offset by increased additional paid-in capital of $10 million related to changes in noncontrolling interest and stock compensation.

Calculation of Earnings (Loss) Per Share (EPS)

Diluted net income (loss) per share is computed by dividing net income (loss) attributable to shareholders, including adjustments to the redemption value of redeemable noncontrolling interests, by the basic weighted-average shares outstanding plus all potentially dilutive common shares outstanding during the period. The following table provides a reconciliation of net income (loss) attributable to shareholders to the numerator in the diluted earnings per share calculation, together with the resulting earnings per share amounts:⁴

OCTAVE SPECIALTY GROUP, INC. AND SUBSIDIARIES

Consolidated Statements of Income (Loss) (Unaudited)⁵

OCTAVE SPECIALTY GROUP, INC. AND SUBSIDIARIES

Consolidated Balance Sheets⁶

Non-GAAP Financial Data

In addition to reporting the Company’s quarterly financial results in accordance with GAAP, the Company is reporting non-GAAP financial measures: EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin, Organic Revenue Growth Rate (Insurance Distribution segment only), Adjusted Net Income and Adjusted Net Income Margin. These amounts are derived from our consolidated financial information, but are not presented in our consolidated financial results because they are not calculated in accordance with GAAP.

We present non-GAAP supplemental financial information because we believe such information is of interest to the investment community, and that it provides greater transparency and enhanced visibility into the underlying drivers and performance of our businesses on a basis that may not be otherwise apparent on a GAAP basis. We view these non-GAAP financial measures as important indicators when assessing and evaluating our performance on a segmented and consolidated basis, and they are presented to improve the comparability of our results between periods by eliminating the impact of the items that may not be representative of our core operating performance. These non-GAAP financial measures are not substitutes for the Company’s GAAP reporting, should not be viewed in isolation, and may differ from similar reporting provided by other companies, which may define non-GAAP measures differently

The following paragraphs define each non-GAAP financial measure. A tabular reconciliation of the non-GAAP financial measure to the most comparable GAAP financial measure is also presented below.

Non-GAAP Financial Measures

Organic Revenue Growth & Rate (Insurance Distribution Only) — Organic revenue is based on commissions and fees for the relevant period by excluding (i) the first twelve months of commissions and fees generated from acquisitions, (ii) commissions and fees from divestitures and (iii) other items such as contingent commissions, profit commissions and the impact of changes in foreign exchange rates.

Organic Revenue Growth is the change in organic revenue period-to-period, with prior period results adjusted to (i) include commissions and fees that were excluded from organic revenue in the prior period and reached the twelve-month owned mark in the current period, and (ii) exclude commissions and fees related to divestitures from organic revenue.

Total Specialty P&C Insurance Production includes gross premiums written by Octave's Specialty P&C Insurance segment and premiums placed by the Insurance Distribution segment. Specialty P&C Insurance revenues are dependent on gross premiums written, as specialty program insurance companies earn premiums based on the portion of gross premiums written retained (i.e., net premiums written) and fees on gross premiums written that are ceded to reinsurers. Insurance Distribution revenues are dependent on premium volume, as Managing General Agents/Underwriters and brokers receive commissions based on the amount of premiums placed (i.e., gross premiums written on behalf of insurance carriers) with insurance carriers.

EBITDA — EBITDA is net income (loss) from continuing operations before interest expense, income taxes, depreciation and amortization of intangible assets.

EBITDA Margin — EBITDA divided by total revenues.

Adjusted EBITDA and Adjusted EBITDA Margin —... (truncated) or non-recurring items, including those related to raising capital. We believe that Adjusted EBITDA is an appropriate measure of operating performance because it eliminates the impact of income and expenses that may obfuscate business performance, and that the presentation of this measure enhances an investor's understanding of our financial performance.

Adjusted Net Income and Adjusted Net Income Margin — We define Adjusted Net Income as net income (loss) from continuing operations attributable to Octave adjusted for amortization of intangible assets, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, acquisition and integration-related expenses, severance and non-recurring income and loss items that, in the opinion of management, significantly affect the period-over-period assessment of operating results, and the related tax effect of those adjustments. Per share amounts exclude any impact of revaluing noncontrolling interests⁷ as otherwise reported under GAAP earnings per share. We believe that Adjusted Net Income is an appropriate measure of operating performance because it eliminates the impact of income and expenses that may obfuscate business performance.

Results of Operations by Segment

(Continued)⁸⁹

Organic Growth

(1)

Total Insurance Distribution revenue includes investment income

(2)

Change in accounting in 1Q26 related to an MGA contracts on a net basis, normalizing the prior year for consistency.

Total Specialty P&C Insurance Production

Specialty P&C Insurance production includes gross premiums written by Octave's Specialty P&C Insurance segment and premiums placed by the Insurance Distribution segment.

About Octave

Octave Specialty Group, Inc. is a global specialty insurance firm that builds, buys, and scales niche insurance distribution and underwriting businesses. With a focus on operational excellence, disciplined growth, and innovation, Octave is creating a harmonized portfolio of companies that deliver exceptional performance and long-term value for shareholders. For more information, visit www.octavegroup.com.

The Amended and Restated Certificate of Incorporation of Octave contains substantial restrictions on the ability to transfer Octave’s common stock. Subject to limited exceptions, any attempted transfer of common stock shall be prohibited and void to the extent that, as a result of such transfer (or any series of transfers of which such transfer is a part), any person or group of persons shall become a holder of 5% or more of Octave’s common stock or a holder of 5% or more of Octave’s common stock increases its ownership interest.

Contact

Karen Beyer

Managing Director, Investor Relations

(212) 208-3222 ir@octavegroup.com

Financial statements

Income Statement

Octave's First Quarter 2026 Summary Results (in thousands, except per share data)

Octave's First Quarter 2026 Summary Results – Three Months Ended March 31, – 2026Octave's First Quarter 2026 Summary Results – Three Months Ended March 31, – 2025Octave's First Quarter 2026 Summary Results – Three Months Ended March 31, – % Change
Total revenues from continuing operations104,17062,75666.0%
Total expenses from continuing operations107,51477,86338.0%
Pretax income (loss) from continuing operations-3,344-15,107-78.0%
Provision (benefit) for income taxes from continuing operations-481-617NM
Net income (loss) from continuing operations-2,863-14,490-80.0%
Net income (loss) from continuing operations attributable to shareholders, net of tax-6,851-16,144-58.0%
Net income (loss) from discontinued operations$—-30,247NM
Net income (loss) attributable to shareholders-6,851-46,391NM
Net income (loss) from continuing operations attributable to stockholders per diluted share 3-0.13-0.57-77.0%
Net income (loss) attributable to stockholders per diluted share 3-0.13-1.21-89.0%
Non-GAAPEBITDA to shareholders 23,610-5,477-166.0%
Non-GAAPAdjusted EBITDA to shareholders220,069-1,287NM
Non-GAAPAdjusted net income (loss) attributable to shareholders16,615-6,037-375.0%
Per ShareAdjusted net income (loss) to shareholders per diluted share 20.37-0.13-385.0%
Per ShareAdjusted EBITDA to shareholders per diluted share20.44-0.03NM
Per ShareWeighted-average diluted shares outstanding45,30347,313-4.0%

Income Statement

Three Months Ended March 31, — Insurance Distribution Segment (in thousands)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025Three Months Ended March 31, – % Change
Premiums placed426,833233,18683.0%
Total revenues78,52640,99892.0%
Pretax income (loss)16,785-2,243-848.0%
Pretax income (loss) to shareholders112,797-3,897-428.0%
Net income (loss)17,153-1,743-1084.0%
Net income (loss) to shareholders113,165-3,397-488.0%
EBITDA30,81712,083155.0%
EBITDA to shareholders123,4677,083231.0%
Adjusted EBITDA32,99512,112172.0%
Adjusted EBITDA to shareholders125,3407,112256.0%
Adjusted net income (loss)28,7497,049308.0%
Adjusted net income (loss) to shareholders22,0452,549765.0%
Pretax income margin to shareholders216.3%-9.5%2580.0%
Adjusted EBITDA margin to shareholders3,432.3%17.3%1500.0%
Organic Growth41.8%-2.1%

Income Statement

Three Months Ended March 31, — Specialty Property & Casualty Insurance Segment (in thousands)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025Three Months Ended March 31, – % Change
Gross premium written103,71686,91519.0%
Net premiums written32,44918,00480.0%
Net premiums earned20,00115,67828.0%
Total revenue25,29921,17119.0%
Net income (loss)-7,6901,425-640.0%
Adjusted EBITDA to shareholders(1)1,6181,5892.0%
Loss Ratio98.4%66.9%3150.0%
Expense Ratio51.3%35.2%1610.0%
Combined Ratio149.7%102.1%4760.0%

Income Statement

Three Months Ended March 31, (in thousands, except per share data)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Net income (loss) from continuing operations attributable to shareholders-6,851-16,144
Adjustment for Redeemable NCI807-10,825
Numerator of diluted EPS-6,044-26,969
Per Share — Diluted-0.13-0.57
Net income (loss) attributable to shareholders-6,851-46,391
Adjustment for Redeemable NCI807-10,825
Numerator of diluted EPS-6,044-57,216
Per Share — Diluted-0.13-1.21
WASO-Diluted45,30347,313

Income Statement

Three Months Ended March 31, — Consolidated Statements of Income (Loss) (Unaudited) ($ in thousands, except share data)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Commissions68,17836,771
Servicing and other fees9,3624,964
Net premiums earned20,00115,678
Program fees3,6443,652
Investment income2,3552,815
Other630-1,124
Total revenues104,17062,756
Expenses:Commissions14,00510,365
Expenses:Losses and loss adjustment expenses19,67910,496
Expenses:Policy acquisition costs6,3713,841
Expenses:General and administrative53,15538,531
Expenses:Intangible amortization and depreciation12,2149,176
Expenses:Interest2,0905,454
Expenses:Total expenses107,51477,863
Expenses:Pretax income (loss) from continuing operations-3,344-15,107
Expenses:Provision (benefit) for income taxes from continuing operations-481-617
Expenses:Net income (loss) from continuing operations-2,863-14,490
Expenses:Net income (loss) from discontinued operations-30,247
Expenses:Net income (loss)-2,863-44,737
Expenses:Net (gain) loss attributable to noncontrolling interest-3,988-1,654
Expenses:Net income (loss) attributable to shareholders-6,851-46,391
Expenses:Net income (loss) from continuing operations attributable to stockholders-6,851-16,144
Expenses:Net income (loss) from discontinued operations attributable to stockholders-30,247
Expenses:Net income (loss) attributable to shareholders-6,851-46,391
Net income (loss) from continuing operations per share attributable to stockholdersBasic-0.13-0.57
Net income (loss) from continuing operations per share attributable to stockholdersDiluted-0.13-0.57
Net income (loss) per share attributable to stockholdersBasic-0.13-1.21
Net income (loss) per share attributable to stockholdersDiluted-0.13-1.21

Income Statement

Three Months Ended March 31, 2026 — (Continued) (in thousands)

Three Months Ended March 31, 2026 – Specialty Property & Casualty InsuranceThree Months Ended March 31, 2026 – Insurance DistributionThree Months Ended March 31, 2026 – Corporate & OtherThree Months Ended March 31, 2026 – Consolidated
Gross premiums written103,716103,716
Net premiums written32,44932,449
Total revenues25,29978,526345104,170
Total expenses33,58161,74112,192107,514
Pretax income (loss)-8,28216,785-11,847-3,344
Provision (benefit) for income taxes-592-368479-481
Net income (loss)-7,69017,153-12,326-2,863
Adjustments to EBITDAAdd: Interest expense2,0902,090
Adjustments to EBITDAAdd: Income tax expense-592-368479-481
Adjustments to EBITDAAdd: Depreciation295272567
Adjustments to EBITDAAdd: Intangible amortization11,64711,647
Adjustments to EBITDAEBITDA-8,28230,817-11,57510,960
Adjustments to EBITDAEBITDA attributable to shareholders-8,28223,467-11,5753,610
Adjustments to Adjusted EBITDAAdd: Acquisition and integration-related expenses1,4041,0642,468
Adjustments to Adjusted EBITDAAdd: Equity-based compensation expense6977743,1214,592
Adjustments to Adjusted EBITDAAdd: Severance and restructuring expense1,2914191,710
Adjustments to Adjusted EBITDAAdd: Other non-operating (income) losses7,912827,994
Adjustments to Adjusted EBITDAAdjusted EBITDA1,61832,995-6,88927,724
Adjustments to Adjusted EBITDAAdjusted EBITDA attributable to shareholders1,61825,340-6,88920,069
Adjustments to Adjusted EBITDANet income (loss)-7,69017,153-12,326-2,863
Adjustments:Add: Acquisition and integration-related expenses1,4041,0642,468
Adjustments:Add: Intangible amortization11,64711,647
Adjustments:Add: Equity-based compensation expense6977743,1214,592
Adjustments:Add: Severance and restructuring expense1,2914191,710
Adjustments:Add: Other non-operating (income) losses7,912827,994
Adjustments:Adjusted net income (loss) before tax and NCI2,21030,978-7,64025,548
Adjustments:Income tax effects-1,055-2,2291,055-2,229
Adjustments:Adjusted net income (loss) before NCI1,15528,749-6,58523,319
Adjustments:Net (income) loss attributable to noncontrolling interest-6,704-6,704
Adjustments:Adjusted net income (loss) attributable to shareholders1,15522,045-6,58516,615
Adjustments:Net income (loss) margin-30.421.8NM-2.7
Adjustments:Adjusted EBITDA Margin6.442NM26.6
Adjustments:Adjusted EBITDA Margin to shareholders6.432.3NM19.3
Adjustments:Adjusted net income (loss) after NCI margin4.628.1NM15.9

Income Statement

Three Months Ended March 31, 2025 — (Continued) (in thousands)

Three Months Ended March 31, 2025 – Specialty Property & Casualty InsuranceThree Months Ended March 31, 2025 – Insurance DistributionThree Months Ended March 31, 2025 – Corporate & OtherThree Months Ended March 31, 2025 – Consolidated
Gross premiums written86,91586,915
Net premiums written18,00418,004
Total revenues from Continuing Operations21,17140,99858762,756
Total expenses from Continuing Operations19,66843,24114,95477,863
Pretax income (loss)1,503-2,243-14,367-15,107
Provision (benefit) for income taxes78-500-195-617
Net income (loss) from Continuing Operations1,425-1,743-14,172-14,490
Adjustments to EBITDAAdd: Interest expense5,4545,454
Adjustments to EBITDAAdd: Income tax expense78-500-195-617
Adjustments to EBITDAAdd: Depreciation109304413
Adjustments to EBITDAAdd: Intangible amortization8,7638,763
Adjustments to EBITDAEBITDA from Continuing Operations1,50312,083-14,063-477
Adjustments to EBITDAEBITDA from Continuing Operations attributable to shareholders1,5037,083-14,063-5,477
Adjustments to Adjusted EBITDAAdd: Acquisition and integration-related expenses682682
Adjustments to Adjusted EBITDAAdd: Equity-based compensation expense861,5741,660
Adjustments to Adjusted EBITDAAdd: Severance and restructuring expense291,8191,848
Adjustments to Adjusted EBITDAAdjusted EBITDA1,58912,112-9,9883,713
Adjustments to Adjusted EBITDAAdjusted EBITDA to attributable to shareholders1,5897,112-9,988-1,287
Adjustments to Adjusted EBITDANet income (loss) (Continuing Operations)1,425-1,743-14,172-14,490
Adjustments:Add: Acquisition and integration-related expenses682682
Adjustments:Add: Intangible amortization8,7638,763
Adjustments:Add: Equity-based compensation expense861,5741,660
Adjustments:Add: Severance and restructuring expense291,8191,848
Adjustments:Adjusted net income (loss) before tax and NCI1,5117,049-10,097-1,537
Adjustments:Adjusted net income (loss) before NCI1,5117,049-10,097-1,537
Adjustments:Net (income) loss attributable to noncontrolling interest-4,500-4,500
Adjustments:Adjusted net income (loss) attributable to shareholders1,5112,549-10,097-6,037
Adjustments:Net income (loss) margin6.7-4.3NM-23.1
Adjustments:Adjusted EBITDA Margin7.529.5NM5.9
Adjustments:Adjusted EBITDA Margin to shareholders7.517.3NM-2.1

Balance Sheet

March 31, 2026 — Consolidated Balance Sheets ($ in thousands, except share data)

March 31, 2026 – (Unaudited)December 31, 2025
Fixed maturity securities, at fair value (amortized cost: $139,242 and $123,414)137,092122,295
Short-term investments, at fair value (amortized cost: $92,295 and $146,434)92,295146,442
Other investments (includes $7,454 and $7,454 at fair value)24,97124,971
Total investments (net of allowance for credit losses of $0 and $0)254,358293,708
Cash and cash equivalents (including $46,634 and $40,754 of restricted cash)93,53768,440
Premium receivables (net of allowance for credit losses of $500 and $500)87,65375,085
Commission and fees receivable106,19886,549
Reinsurance recoverable on paid and unpaid losses (net of allowance for credit losses of $100 and $100)469,859436,092
Deferred ceded premium145,420146,365
Policy acquisition costs16,4519,732
Intangible assets, less accumulated amortization458,380474,998
Goodwill533,497540,345
Other assets (net of allowance for credit losses of $350 and $350)101,67392,003
Total assets2,267,0262,223,317
Liabilities:Unearned premiums198,681187,178
Liabilities:Loss and loss adjustment expense reserves487,261459,990
Liabilities:Ceded premiums payable89,14880,561
Liabilities:Deferred program fees and reinsurance commissions6,9296,978
Liabilities:Commission payable118,086115,555
Liabilities:Deferred taxes60,55365,217
Liabilities:Long-term debt117,062117,558
Liabilities:Accrued interest payable1,3051,343
Liabilities:Other liabilities158,458102,771
Liabilities:Total liabilities1,237,4831,137,151
Liabilities:Redeemable noncontrolling interest195,969252,981
Stockholders’ equity:Common stock, par value $0.01 per share; 130,000,000 shares authorized; issued shares: 48,876,882 and 48,876,882489489
Stockholders’ equity:Additional paid-in capital380,263369,860
Stockholders’ equity:Accumulated other comprehensive income1,2248,483
Stockholders’ equity:Retained earnings363,751370,431
Stockholders’ equity:Treasury stock, shares at cost: 3,863,290 and 3,871,598-33,109-33,473
Stockholders’ equity:Total Octave Specialty Group, Inc. stockholders’ equity712,618715,790
Stockholders’ equity:Nonredeemable noncontrolling interest120,956117,395
Stockholders’ equity:Total stockholders’ equity833,574833,185
Stockholders’ equity:Total liabilities, redeemable noncontrolling interest and stockholders’ equity2,267,0262,223,317
Full release

Forward-Looking Statements

This press release, and any related oral statements, contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as “estimate,” “project,” “plan,” “believe,” “anticipate,” “intend,” “planned,” “potential” and similar expressions, or future or conditional verbs such as “will,” “should,” “would,” “could,” and “may,” or the negative of those expressions or verbs, identify forward-looking statements. We caution readers that these statements are not guarantees of future performance. Forward-looking statements are not historical facts, but instead represent only our beliefs regarding future events, which may by their nature be inherently uncertain and some of which may be outside our control. These statements may relate to plans and objectives with respect to the future, among other things, which may change. We are alerting you to the possibility that our actual results may differ, possibly materially, from the expected objectives or anticipated results that may be suggested, expressed or implied by these forward-looking statements. Important factors that could cause our results to differ, possibly materially, from those indicated in the forward-looking statements include, among others, those discussed under “Risk Factors.” in our most recent SEC filed quarterly or annual report.¹⁰

Any or all of management’s forward-looking statements, whether contained herein or in other publications, may prove to be incorrect and are based on management’s current belief or opinions. Octave Specialty Group’s (“OSG”) and its subsidiaries’ (collectively, “Octave” or the “Company”) actual results may differ materially from those expressed in, or implied by, these forward-looking statements, and there are no guarantees about the performance of Octave’s securities. Among events, risks, uncertainties or factors that could cause actual results to differ materially are: (1) the high degree of volatility in the price of OSG’s common stock; (2) uncertainty concerning the Company’s ability to achieve value for holders of its securities from the specialty property and casualty insurance business, the insurance distribution... (truncated)ons in their performance; (7) inability to obtain reinsurance coverage on economic terms; (8) loss of key relationships for the production of business in our specialty property and casualty and insurance distribution businesses or the inability to secure such additional relationships to produce expected results; (9) the impact of catastrophic public health events, environmental or natural events, or political events, including as a result of global or regional conflicts; (10) restrictive covenants in agreements and instruments that impair Octave’s ability to pursue or achieve its business strategies; (11) regulatory risks, including disagreements with insurance regulators, changes in laws or regulations, and the Company’s ability to adapt to an evolving regulatory environment; (12) risks related to changes in the composition, valuation, or performance of the Company’s investment portfolio, including interest rate and foreign currency exchange rate fluctuations; (13) events or circumstances that result in the impairment of our intangible assets and/or goodwill that were recorded in connection with Octave’s acquisitions; (14) the risk of litigation, regulatory inquiries, investigations, claims or proceedings, and the risk of adverse outcomes in connection therewith; (15) system security risks, data protection breaches and cyberattacks; (16) our inability to attract and retain qualified executives, senior managers and other employees, or the loss of such personnel; (17) greater competition for our specialty property and casualty insurance business and/or our insurance distribution business; (18) loss or lowering of the AM Best rating for our property and casualty insurance company subsidiaries; (19) disintermediation within the insurance industry or greater competition from technology-based insurance solutions or non-traditional insurance markets; (20) changes in law or in the functioning of the healthcare market that impair the business model of our accident and health managing general agents; (21) failure to successfully execute business expansion initiatives, integrate acquired businesses, or realize anticipated benefits from such efforts and significant obligations under put rights granted in completed acquisitions; and (22) other risks and uncertainties that have not been identified at this time.¹¹

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Octave Specialty Group earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.